Dalvir S. Gill

Dalvir S. Gill

Plus aucun poste en cours
68 ans
Health Technology
Consumer Services
Commercial Services

Profil

Dalvir S.
Gill
served as the Chief Executive Officer & Director at Transcelerate Biopharma, Inc. from 2013 to 2023.
He also held positions as Director-Health Outcomes Research at Rhone-Poulenc Rorer, Inc., Independent Director at Panbela Therapeutics, Inc., and President-Phase II & IV Development at inVentiv Health Clinical, Inc. In 2012, he briefly served as President-Drug Development at PharmaNet, Inc. Gill holds a doctorate from the University of London and an undergraduate degree from the University of Hertfordshire.

Anciens postes connus de Dalvir S. Gill

SociétésPosteFin
Directeur Général 01/01/2023
SUN BIOPHARMA INC Directeur/Membre du Conseil 30/08/2018
Corporate Officer/Principal 01/12/2012
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Dalvir S. Gill

Formation de Dalvir S. Gill

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

13

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Commercial Services

Distribution Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Dalvir S. Gill